Taro, Execs Receive DOJ Subpoenas Over Generic Drug Prices
The U.S. Department of Justice has sent grand jury subpoenas to Taro Pharmaceuticals USA Inc. and two of its senior officers seeking information on its pricing of generic drugs and communications...To view the full article, register now.
Already a subscriber? Click here to view full article